Stay updated with breaking news from Initial Determination. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Following the grant of institution of a recent IPR petition in the matter of Satco Products, Inc. v. The Regents of the University of California, IPR2021-00662, Paper 26 (PTAB Feb. 11,...
In Ingevity Corporation v. International Trade Commission,1 the Federal Circuit held that a prior invention will not anticipate under 35 U.S.C. § 102(g) unless the prior inventors appreciated the invention.
In its 2018 decision in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., the Supreme Court held that an inventor's sale of an invention to a third party who is obligated to keep the invention confidential can create an on-sale bar under AIA §102(a).
In its 2018 decision in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., the Supreme Court held that an inventor's sale of an invention to a third party who is obligated to keep the invention confidential can create an on-sale bar under AIA §102(a).
In In re Certain High-Potency Sweeteners, the issue at the heart of the decision was whether the Leahy-Smith America Invents Act’s AIA amendments to the on-sale bar in 35 U.S.C. §102 modified pre-AIA law regarding the sale of products made with a secret process.